Physician

Yang Xu

According to 2025 Medicare claims, Yang Xu (NPI: 1154526515) practices internal medicine in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is HOT SPRINGS INTERNAL MEDICINE CLINIC PLLC (NPI: 1275110181; TIN: 862286067) and primary practice location at 71901-4027. Xu is affiliated with the Aledade 93 National MSSP Enhanced (ACO ID: A5206), participating under the MSSP model.

Xu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 362 traditional Medicare patients, billed 3,179 HCPCS/CPT codes, and received $180,458 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,432 prescription claims across 647 beneficiaries totaling $760,904 in drug costs, led by Eliquis (Apixaban). DME data shows 347 claims. Open Payments data shows 31 records totaling $573. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $262,804 to $180,458. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $28,919 and ending at $25,918.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	791	10,550	$262,804
2016	700	12,047	$251,683
2017	835	13,122	$254,421
2018	770	13,966	$275,084
2019	654	12,314	$247,601
2020	576	12,598	$168,397
2021	527	6,567	$162,685
2022	390	2,632	$166,481
2023	393	2,851	$181,889
2024	362	3,179	$180,458

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	912	11,150	$636,361
2016	797	11,231	$612,390
2017	855	11,294	$608,213
2018	864	11,921	$655,908
2019	779	11,931	$699,734
2020	746	11,271	$677,560
2021	755	9,347	$606,358
2022	587	8,317	$591,542
2023	598	9,445	$788,514
2024	647	10,432	$760,904

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	205	666	$30,257
2016	192	663	$25,503
2017	143	492	$18,332
2018	93	251	$9,192
2019	101	344	$10,184
2020	62	297	$7,594
2021	65	209	$4,660
2022	66	239	$9,166
2023	38	258	$14,297
2024	57	347	$21,344

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	270	270	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	343	1,031	$77
G0008	Administration of influenza virus vaccine	98	99	$29
G0442	Annual alcohol misuse screening, 5 to 15 minutes	274	274	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	305	696	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	61	4,005	$77,843
Ozempic	Semaglutide	66	2,426	$69,324
Januvia	Sitagliptin Phosphate	67	4,082	$69,323
Rybelsus	Semaglutide	24	1,800	$55,913
Farxiga	Dapagliflozin Propanediol	61	2,470	$45,106

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	27	$10,707
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	26	$1,777
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	16	$1,515
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	23	$1,189
A7030	Full face mask used with positive airway pressure device, each	N	N/R	15	$1,164

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$573	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yang Xu?

Tedicare shows public-source Medicare data for Yang Xu (NPI 1154526515), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yang Xu have ACO affiliation data?

Yang Xu is shown with ACO affiliation data for Aledade 93 National MSSP Enhanced (MSSP, ACO ID A5206).

What billing organization is linked to Yang Xu?

Yang Xu is linked to HOT SPRINGS INTERNAL MEDICINE CLINIC PLLC (billing NPI 1275110181) in the available physician profile data.

Does Yang Xu have Open Payments data?

Yang Xu has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.